New York residents who have type 2 diabetes may be interested in a study that found that a new class of drugs, SGLT2 inhibitors, could raise the risk of a complication known as ketoacidosis. However, although the condition can be deadly, it is also rare, and experts say this should not deter people from taking the class of drugs. Researchers said only about 1 in 1,000 people using SGLT2 inhibitors would develop the condition.

New York residents may be familiar with a condition called pneumothorax, also known as a collapsed lung. This condition happens when air, which usually circulates inside the lungs, leaks and becomes trapped in the pleural space around the lungs. As this air builds up, it puts pressure on the lungs and causes them to collapse. Typically, however, it only causes a part of the lung to collapse.